The leading MIDD consultancy in the world

We are the leading and largest model-informed drug development (MIDD) consultancy in the world, which enables us to assure that various career pathways are offered to match the ambition and personal interests of our employees.

The Integrated Drug Development Team at Certara delivers value by applying MIDD concepts and solutions into the most crucial drug development deliverables – to inform internal decision-making and strengthen global regulatory submissions.  Leveraging our experience in working on thousands of drug development projects on behalf of hundreds of biopharma companies, we bring a track record of success and a broad range of expertise to each assignment.

Be a part of Certara’s growing global team of leading experts and make a difference in the world.

  • Collaborate with leading drug development experts
  • Work on a wide range of innovative drug development programs
  • Enjoy flexibility, competitive benefits and a culture of passion and fun

Clinical Pharmacologist

As a clinical pharmacologist, you will help lead client early development, clinical pharmacology, and regulatory science project engagements.  In this role, you will support the design, execution, and management of high-quality clinical pharmacology/DMPK studies. Clinical Pharmacologists have a pivotal role in assisting the team as we provide strategic clinical pharmacology guidance on drug development.

This is an opportunity to join multidisciplinary teams to execute clinical pharmacology programs for crucial new medicines that matter for patients.

Apply now
Clinical Pharmacologist
Associate Director or Director of Pharmacometrics

Associate Director or Director of Pharmacometrics

Our pharmacometricians are responsible for supporting quantitative decision-making in drug development through the development and application of population PK, PK/PD, exposure-response and other models.  Deepen your strategic drug development expertise and hone your pharmacometric techniques with fit-for-purpose modeling approaches.

In this role, you will broaden your experience by working with a wide range of companies, molecular modalities, and therapeutic areas.  Pave your consulting career path by seeking and seizing opportunities that match your professional development goals.

Apply now

Director of Model-based Meta-analysis

The Director of Model-based Meta-analysis (MBMA) supports client early and late clinical development engagements by providing evaluations that address key questions in their:

  • development programs
  • clinical study design considerations
  • model-informed drug development strategies
  • interactions with and submissions to regulatory authorities

We are looking for candidates with demonstrated MBMA experience, to conduct exploratory as well as more formal MBMA analyses across a wide range of therapeutic areas, support clients in the interpretation of MBMA results and how those may impact decision making within their development programs.

Apply now
Director of Model-based Meta-analysis
A Taylor
Adekemi Taylor Sr. Director, Integrated Drug Development

Dr. Taylor joined Certara in March 2011. She holds a PhD in Chemical Engineering from Pennsylvania State University.  At Certara, Dr. Taylor leads consultancy projects, performing population PK, PK/PD, efficacy and safety exposure-response, and concentration-QTc modeling to support regulatory filings, study design and general drug development.

Matthew Zierhut Vice President, Integrated Drug Development

At Certara, Dr. Matthew Zierhut advances the integration of external aggregate clinical trial data into development decisions and commercial and regulatory strategy via model-based meta-analysis (MBMA).  Matt works closely with clinical development teams to ensure MBMA is leveraged for optimal impact when making the most critical decisions.

Back to top